News and Media

UK government set for psychedelics investment windfall

The UK government is on track for a seven-figure windfall from an investment in a psychedelic drugs company that is readying a float on the Toronto stock exchange.

State-backed investor Angel CoFund holds a 5.5 per cent stake in London-based Small Pharma, which has announced its intention to list via a reverse takeover through the Canadian capital pool company Unilock Capital Corp.

READ THE FULL FINANCIAL TIMES ARTICLE HERE

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: